UK markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
79.16-3.12 (-3.79%)
At close: 1:00PM EST
78.85 -0.31 (-0.39%)
After hours: 04:58PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
7,197,000
7,067,000
9,843,000
6,220,000
2,394,000
Depreciation & amortisation
3,401,000
3,625,000
3,652,000
4,519,000
4,637,000
Deferred income taxes
-672,000
-668,000
-556,000
-509,000
-2,621,000
Stock-based compensation
506,000
475,000
417,000
348,000
312,000
Change in working capital
-2,900,000
-4,590,000
-2,067,000
-1,553,000
-5,021,000
Accounts receivable
-
-1,002,000
294,000
-418,000
297,000
Inventory
-
-855,000
-508,000
-911,000
-145,000
Accounts payable
-
724,000
399,000
230,000
254,000
Other working capital
8,158,000
5,569,000
9,967,000
8,307,000
4,559,000
Other non-cash items
4,147,000
2,611,000
1,177,000
1,628,000
769,000
Net cash provided by operating activities
13,084,000
10,253,000
13,440,000
10,922,000
6,447,000
Cash flows from investing activities
Investments in property, plant and equipment
-4,926,000
-4,684,000
-3,473,000
-2,615,000
-1,888,000
Acquisitions, net
-4,797,000
-6,606,000
-4,954,000
-431,000
-396,000
Purchases of investments
-1,018,000
-1,095,000
-3,202,000
-7,994,000
-10,739,000
Sales/maturities of investments
1,415,000
2,812,000
8,622,000
15,252,000
15,664,000
Other investing activities
7,000
130,000
378,000
102,000
38,000
Net cash used for investing activities
-9,284,000
-9,443,000
-2,629,000
4,314,000
2,679,000
Cash flows from financing activities
Debt repayment
-1,156,000
-1,957,000
0
-4,287,000
-1,103,000
Common stock repurchased
-822,000
-1,281,000
-4,780,000
-9,091,000
-4,014,000
Dividends paid
-6,509,000
-6,215,000
-5,695,000
-5,172,000
-5,167,000
Other financing activities
8,783,000
-436,000
5,000
-325,000
-195,000
Net cash used provided by (used for) financing activities
-738,000
-2,832,000
-8,861,000
-13,160,000
-10,006,000
Net change in cash
2,657,000
-1,769,000
1,967,000
1,871,000
-423,000
Cash at beginning of period
7,401,000
9,934,000
7,967,000
6,096,000
6,515,000
Cash at end of period
9,959,000
8,165,000
9,934,000
7,967,000
6,092,000
Free cash flow
Operating cash flow
13,084,000
10,253,000
13,440,000
10,922,000
6,447,000
Capital expenditure
-4,926,000
-4,684,000
-3,473,000
-2,615,000
-1,888,000
Free cash flow
8,158,000
5,569,000
9,967,000
8,307,000
4,559,000